Anti-HINT3 antibody (1-182) (STJ11100494)

SKU:
STJ11100494

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-HINT3 (1-182) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: HINT3
Gene ID: 135114
Uniprot ID: HINT3_HUMAN
Immunogen Region: 1-182
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 1-182 of human HINT3 (NP_612638.3).
Immunogen Sequence: MAEEQVNRSAGLAPDCEASA TAETTVSSVGTCEAAGKSPE PKDYDSTCVFCRIAGRQDPG TELLHCENEDLICFKDIKPA ATHHYLVVPKKHIGNCRTLR KDQVELVENMVTVGKTILER NNFTDFTNVRMGFHMPPFCS ISHLHLHVLAPVDQLGFLSK LVYRVNSYWFITADHLIEKL RT
Function Exhibits adenosine 5'-monophosphoramidase activity, hydrolyzing purine nucleotide phosphoramidates with a single phosphate group such as adenosine 5'monophosphoramidate (AMP-NH2) to yield AMP and NH2. Hydrolyzes lysyl-AMP (AMP-N-epsilon-(N-alpha-acetyl lysine methyl ester)) generated by lysine tRNA ligase. Hydrolyzes 3-indolepropionic acyl-adenylate and fluorogenic purine nucleoside tryptamine phosphoramidates in vitro.
Protein Name Adenosine 5'-Monophosphoramidase Hint3
Histidine Triad Nucleotide-Binding Protein 3
Hint-3
Cellular Localisation Cytoplasm
Nucleus
Localized As Aggregates In The Cytoplasm And The Nucleus
Alternative Antibody Names Anti-Adenosine 5'-Monophosphoramidase Hint3 antibody
Anti-Histidine Triad Nucleotide-Binding Protein 3 antibody
Anti-Hint-3 antibody
Anti-HINT3 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance